Press Release
13 January 2021
DuPont Nutrition & Biosciences announced today the mechanical completion of its new Flexiblend facility in Singapore. The new plant will leverage on DuPont’s advanced biotechnology and global quality standards to provide customized solutions to industry partners in Asia Pacific and will begin operations in 2nd quarter of 2021.
Overcoming the challenges that COVID-19 created, the construction team sought alternative ways to ensure that this state-of-the art facility would become a reality with minimal delay. From using virtual reality technology to compensate for the distance between global and local engineering teams, to creating temporary on-site living quarters for the crew to adhere to safety guidelines, the team delivered mechanical completion of the plant efficiently.
Biotechnology solutions produced in the plant will include flexible blending of enzymes, customized for Asia. Enzymes are highly specialized proteins that improve the sustainability of conventional processes by reducing the use of chemicals, enabling energy efficiency, water efficiency, and waste reduction. Enzymes are used in a wide range of applications such as animal nutrition, grain processing, home care, food & beverage and many others.
“We are proud that despite the circumstances, we were successfully able to build a state-of-the-art facility that will offer local customization with world-class quality within the region. The creativity of the team to utilize virtual reality technology to eliminate distance between our global and local engineering teams and receive expert support certainly helped to make this facility a reality.”
Katariina Rasinmaki
Global Manufacturing & Supply Chain Leader
DuPont Nutrition & Biosciences
“The new facility is a testament to our commitment to deliver flexible local solutions based on global science, empowering and easing the daily challenges of our customers. The strategic location of the new facility will also reduce the supply lead time, thus minimizing barriers for potential supply chain constraints. We are thankful to the Singapore government for extending their support to help us navigate the unexpected challenges and manage risks, ensuring business continuity.”
Vik Prabhu
Regional Director, Asia Pacific, Health & Biosciences
DuPont Nutrition & Biosciences
“DuPont’s new facility is an example of how biotechnology companies can leverage Singapore as a hub to innovate, manufacture and deliver sustainable products and solutions to consumers and industries in the region. We are delighted that DuPont has given us their vote of confidence amidst a challenging global environment. This investment is testimony to the longstanding partnership between DuPont and EDB to capture growth opportunities in the biotechnology industry in order to create good jobs for Singapore and develop a strong base of local talent”
Mr. Ow Kai Onn
Vice President and Head Chemicals & Materials
Economic Development Board (EDB)
Press Release
13 January 2021